Abstract:The link between tumors and the hemostatic system, first of all platelets, has been acknowledged by numerous studies. Platelets activation at the tumor microenvironment and subsequent intravascular clotting are often associated with cancer complications. Recent clinical studies demonstrated that platelet inhibitors substantially decrease risk of tumor metastasis and mortality in cancer patients, thereby emphasizing clinical importance of platelets. However, the precise function of platelets in cancer progression remains enigmatic. Growing tumors secrete a plethora of growth factors and cytokines (tumor secretome) aiming to change its micro- and macro-environment. These factors promote angiogenesis, induce inflammation, and even stimulate changes in bones prior to metastasis. Tumor secretome signals are likely transmitted through the circulation; however, these signals need to be protected from degradation or utilization prior to reaching their target. Due to their ability to intake and secrete back a wide spectrum of proteins, platelets could function as a mobile storage compartment for the tumor secretome. Using platelet infusion and depletion during tumor growth, we assessed the role of platelets in tumor growth and tumor-induced bone remodeling. We demonstrated that platelet infusion stimulates communications between bone marrow and the tumor, while platelet depletion had the opposite effects. Importantly, tumor-induced changes in bone structure were completely abolished in the absence of platelets. Using platelets from knockout mice with various platelet defects, we demonstrated that platelet secretion (but not aggregation) was crucial for their function in tumor progression. In particular, the function of platelet α-granules is essential for the pro-tumorigenic role of platelets. Analysis of the tumor secretome revealed that 77 percent of tumor-secreted factors are highly enriched within platelets over plasma. Several of these factors are essential mediators of bone remodeling. Thus, our data show that platelet α-granule sequestration and secretion represent a cellular mechanism mediating communication between the bone microenvironment and the primary tumor.

Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets

Platelets and circulating (tumor) cells: partners in promoting metastatic cancer

The dynamic role of platelets in cancer progression and their therapeutic implications

Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis

Platelets Are Associated with Xenograft Tumor Growth and the Clinical Malignancy of Ovarian Cancer Through an Angiogenesis-Dependent Mechanism.

Activated platelets facilitate hematogenous metastasis of breast cancer by modulating the PDGFR-β/COX-2 axis

Platelets Promote Breast Cancer Cell MCF-7 Metastasis by Direct Interaction: Surface Integrin Alpha 2 Beta 1-Contacting-mediated Activation of Wnt-beta-catenin Pathway

Purinergic signaling: Diverse effects and therapeutic potential in cancer

Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells

Interaction Between Circulating Cancer Cells and Platelets: Clinical Implication

The critical role of platelet in cancer progression and metastasis

Role of platelets and platelet receptors in cancer metastasis

The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis

Role of Platelet Activation in the Development and Metastasis of Solid Tumors

Role of platelets in inflammation and cancer: novel therapeutic strategies

Platelets and cancer: a casual or causal relationship: revisited

Platelets Involved Tumor Cell EMT During Circulation: Communications and Interventions

Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy

Platelets and the Tumor Cell Microenvironment

Platelets in cancer metastasis: To help the “villain” to do evil

P2Y12 Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment